Company / Tangible Book Value per Share
Corvus Pharmaceuticals, Inc. Tangible Book Value per Share History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Tangible Book Value per Share
$0.53
FY2024
5-year range
$0.53 / $2.45
FY2020-FY2024
Trend
-33.7%
vs FY2023
Sector context
#175 of 211
Health Care
What the data says
Corvus Pharmaceuticals, Inc.'s tangible book value per share of $0.53 is lower than 83% of companies in the Health Care sector (FY2024). Tangible Book Value per Share has declined for 4 consecutive years, from $2.45 in FY2020 to $0.53 in FY2024.
Based on SEC 10-K filings.
0.53 in FY2024 with a 5-year CAGR of -26.1%.
Declined from $1.21 to $0.53 over the past 2 years.
Health Care sector context is included.
Tangible Book Value per Share over time
Growth rates
- 3-Year CAGR
- -38.7%
- 5-Year CAGR
- -26.1%
- 10-Year CAGR
- -
Sector benchmark
-99.6% below sector average
Key checks
Key Insights
- Corvus Pharmaceuticals, Inc.'s tangible book value per share has declined for 4 consecutive years.
- In FY2024, tangible book value per share decreased 33.7% year-over-year.
- Ranks #175 out of 211 companies in the Health Care sector.
- Peak tangible book value per share was recorded in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -0.67 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Tangible Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $0.53 | -33.7% |
| FY2023 | $0.81 | -33.2% |
| FY2022 | $1.21 | -48.1% |
| FY2021 | $2.32 | -5.1% |
| FY2020 | $2.45 | +1.0% |
| FY2019 | $2.42 | -39.6% |
| FY2018 | $4.01 | -3.1% |
| FY2017 | $4.14 | -51.9% |
| FY2016 | $8.61 | +110.3% |
| FY2015 | -$83.24 | -8814.1% |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026